Author

J. Wenzina

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Assay:multiome· 1

Frequent Co-Authors

A. Aloia· 1 shared A. Bileck· 1 shared A. Dzung· 1 shared A. Irmisch· 1 shared A. Leitner· 1 shared A. Othman· 1 shared A. Saltari· 1 shared A. Tastanova· 1 shared

Activity by Year

2022-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

A. Aloia

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintOct 19, 2022

ROS induction as a strategy to target persister cancer cells with low metabolic activity in NRAS mutated melanoma

O. M. Eichhoff, C. I. Stoffel, J. Kaesler…·M. Levesque

The paper identifies ROS induction as a strategy to target MEK-inhibitor resistant NRAS-mutated melanoma cells by exploiting their quiescent metabolic state and elevated baseline ROS levels.

DOI 10.1101/2022.10.19.512839

humanbulk RNA-seq

𝕏 PostBluesky

Cancer BiologybioRxivPreprintApr 4, 2022

Melanoma cells release DEL-1 via small extracellular vesicles

M. Schnödl, F. Tuchmann, J. Wenzina…·P. Petzelbauer

The paper shows melanoma cells release DEL-1 via small extracellular vesicles and demonstrates the potential of sEV proteomics to predict treatment responses in melanoma patients.

DOI 10.1101/2022.04.04.487024

humanproteomics

𝕏 PostBluesky